Saccharomyces boulardii in a child with recurrent Clostridium difficile

被引：15
|
作者：
Ooi, Chee Y.
Dilley, Anthony V. [2 ]
Day, Andrew S. [1 ]
机构：
[1] Univ New S Wales, Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Dept Gastroenterol, Randwick, NSW 2031, Australia
[2] Univ New S Wales, Dept Surg, Sydney, NSW, Australia
来源：
PEDIATRICS INTERNATIONAL | 2009年 / 51卷 / 01期
关键词：
Clostridium difficile infection; Hirschsprung's disease; probiotic; Saccharomyces boulardii; PLACEBO-CONTROLLED TRIAL; DISEASE; PATHOGENESIS; PREVENTION; DIARRHEA;
D O I：
10.1111/j.1442-200X.2008.02782.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：156 / 158
页数：3
相关论文
共 50 条
  • [21] Yeast serine protease from Saccharomyces boulardii protects against Clostridium difficile toxin A.
    Castagliuolo, I
    Qiu, BS
    LaMont, JT
    Pothoulakis, C
    GASTROENTEROLOGY, 1996, 110 (04) : A879 - A879
  • [22] RECURRENT CLOSTRIDIUM-DIFFICILE INFECTION IN A PATIENT WITH SELECTIVE IGG1 DEFICIENCY TREATED WITH INTRAVENOUS IMMUNE GLOBULIN AND SACCHAROMYCES-BOULARDII
    HASSETT, J
    MEYERS, S
    MCFARLAND, L
    MULLIGAN, ME
    CLINICAL INFECTIOUS DISEASES, 1995, 20 : S266 - S268
  • [23] SACCHAROMYCES-BOULARDII INHIBITS CLOSTRIDIUM-DIFFICILE TOXIN-A BINDING AND ENTEROTOXICITY IN RAT ILEUM
    POTHOULAKIS, C
    KELLY, CP
    JOSHI, MA
    GAO, N
    OKEANE, CJ
    CASTAGLIUOLO, I
    LAMONT, JT
    GASTROENTEROLOGY, 1993, 104 (04) : 1108 - 1115
  • [24] Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child
    Smeltzer, Stephanie
    Hassoun, Ali
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (07) : 1688 - 1689
  • [25] PURIFIED SACCHAROMYCES-BOULARDII PROTEASE INHIBITS CLOSTRIDIUM-DIFFICILE TOXIN A EFFECTS IN RAT ILEUM
    CASTAGLIUOLO, I
    LAMONT, JT
    BAKER, C
    GUZMAN, DD
    NIKULASSON, ST
    POTHOULAKIS, C
    GASTROENTEROLOGY, 1995, 108 (04) : A792 - A792
  • [26] Recurrent Clostridium difficile
    Maroo, S
    Lamont, JT
    GASTROENTEROLOGY, 2006, 130 (04) : 1311 - 1316
  • [27] Recurrent Clostridium difficile
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (04): : 268 - 268
  • [28] SUPPRESSION BY SACCHAROMYCES-BOULARDII OF TOXIGENIC CLOSTRIDIUM-DIFFICILE OVERGROWTH AFTER VANCOMYCIN TREATMENT IN HAMSTERS
    ELMER, GW
    MCFARLAND, LV
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) : 129 - 131
  • [29] Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study
    Jeppe West Carstensen
    Mahtab Chehri
    Kristian Schønning
    Steen Christian Rasmussen
    Jacob Anhøj
    Nina Skavlan Godtfredsen
    Christian Østergaard Andersen
    Andreas Munk Petersen
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1431 - 1439
  • [30] AN OPEN TRIAL OF VANCOMYCIN PLUS SACCHAROMYCES-BOULARDII FOR THE TREATMENT OF RELAPSING CLOSTRIDIUM-DIFFICILE DIARRHEA COLITIS
    ELMER, GW
    SURAWICZ, CM
    MCFARLAND, LV
    CHINN, J
    MICROECOLOGY AND THERAPY, VOL 19, 1989, 19 : 251 - 256
12345